
Alexander Kolevzon
Director of the Child Behavioral Health and Science Center · Icahn School of Medicine at Mount Sinai
Credentials: · ·
History
- Present
Child Behavioral Health and Science Center · Icahn School of Medicine at Mount Sinai
- 2004–2005
Child and Adolescent Psychiatry
- 2000–2004
Psychiatry
Research
Synaptic, transcriptional and chromatin genes disrupted in autism
Nature · 2014 · 2,145 citations
Functional impact of global rare copy number variation in autism spectrum disorders
Nature · 2010 · 1,531 citations
Autism genome-wide copy number variation reveals ubiquitin and neuronal genes
Nature · 2009 · 1,075 citations

49 papers

34 papers

26 papers
- MS
22 papers

21 papers
- AT
19 papers

17 papers

16 papers
Grants
- 2014–2030
Developmental Synaptopathies Associated with TSC, PTEN, SHANK3 and SynGAP1 Pathogenic Variants
National Institute of Neurological Disorders and Stroke · U54
Project lead · $2.9M · Boston Children's Hospital
- 2018–2025
Electrophysiological Markers for Interventions in Phelan-McDermid Syndrome and Idiopathic Autism
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $3.7M · Icahn School of Medicine at Mount Sinai
- 2013–2016
Piloting Treatment with Insulin-Like Growth Factor-1 in Phelan-McDermid Syndrome
National Institute of Mental Health · R34
Contact PI · $740.4K · Icahn School of Medicine at Mount Sinai
- 2008–2009
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $814 · Icahn School of Medicine at Mount Sinai
Clinical trials
- 2024–2025
Principal investigator · Completed
Icahn School of Medicine at Mount Sinai
- 2022–2025
A Controlled Trial of Growth Hormone in Phelan-McDermid Syndrome and Idiopathic Autism
Principal investigator · Completed · Phase 2
Icahn School of Medicine at Mount Sinai
- 2020–2021
Low-Dose Ketamine in Children With ADNP Syndrome
Principal investigator · Completed · Phase 1, Phase 2
Alexander Kolevzon
- 2018–2020
AMO-01 to Treat Adolescents and Adults With Phelan-McDermid Syndrome (PMS) and Co-morbid Epilepsy
Principal investigator · Completed · Phase 2
Alexander Kolevzon

